United Laboratories International Holdings Ltd Sustainability Reports
A pharmaceutical group engaged in the research, development, manufacturing, and sales of intermediates, bulk medicine (APIs), and finished medicines, with a focus on antibiotic and insulin products.
Sector: Manufacturing
Country: Hong Kong
Exchange: Hong Kong Stock Exchange
LEI: 2549007JL3XIH77JXN70
FIGI: BBG001SPMVX2
17 reports from 2015 to 2025
- United Laboratories International Holdings Ltd 2025 Environmental, Social and Governance Report
- United Laboratories International Holdings Ltd 2024 Annual Report
- United Laboratories International Holdings Ltd 2024 Environmental, Social and Governance Report
- United Laboratories International Holdings Ltd 2023 Annual Report
- United Laboratories International Holdings Ltd 2023 Environmental, Social and Governance Report